
Deep Dive: Is Medline the Costco of Healthcare? Inside the Biggest IPO of 2025
The Rundown
00:00
Host's investment take and alternatives
Zaid gives his view: strong moat but limited upside, no dividend, and preference for higher-upside IPOs.
Play episode from 08:43
Transcript


